| Schedule of Computing Earnings (Loss) Per Share and the Effect on Income (Loss) |
The following data show the amounts used in computing earnings (loss) per share and the effect on income (loss): | | | Three months ended | | | Six months ended | | | | | June 30, | | | June 30, | | | (in thousands except share and per share data) | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | | | | | | | | | | | | Basic earnings (loss) per share: | | | | | | | | | | | | | | Income (loss) from continuing operations | | $ | 1,891,614 | | | $ | (1,868 | ) | | $ | 1,949,047 | | | $ | (5,320 | ) | | Weighted-average number of shares outstanding | | | 16,540,934 | | | | 1,590,378 | | | | 16,232,377 | | | | 1,587,165 | | | Basic earnings (loss) per share | | $ | 114.40 | | | $ | (1.20 | ) | | $ | 120.10 | | | $ | (3.40 | ) | For the three and six-month periods ended June 30, 2025, the Company reported a net loss. Accordingly, all potentially dilutive securities were excluded from the calculation of diluted loss per share, as their inclusion would have been anti-dilutive. | | | Three months ended | | | Six months ended | | | | | June 30, | | | June 30, | | | (in thousands except share and per share data) | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | | | | | | | | | | | | Diluted earnings (loss) per share: | | | | | | | | | | | | | | Weighted-average number of shares - basic | | | 16,540,934 | | | | 1,590,378 | | | | 16,232,377 | | | | 1,587,165 | | | Effect of dilutive securities: | | | | | | | | | | | | | | | | | | Weighted average number of stock options | | | - | | | | - | | | | - | | | | - | | | Weighted average number of convertible debt | | | 2,637,924 | | | | - | | | | 1,576,763 | | | | - | | | Weighted average number of restricted stock units | | | 28,662 | | | | - | | | | 25,353 | | | | - | | | Weighted average number of warrants | | | 125,944 | | | | - | | | | 125,944 | | | | - | | | Weighted-average number of shares – diluted | | | 19,333,464 | | | | 1,590,378 | | | | 17,960,437 | | | | 1,587,165 | | | Diluted earnings (loss) per share | | $ | 97.80 | | | $ | (1.20 | ) | | $ | 108.50 | | | $ | (3.40 | ) | The following potential Ordinary Shares were excluded from the computation of diluted earnings (loss) per share because their effect would have been anti-dilutive. | | | Three months ended | | | Six months ended | | | | | June 30, | | | June 30, | | | (in thousands except share and per share data) | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | | | | | | | | | | | | Anti-dilutive securities: | | | | | | | | | | | | | | Weighted average number of Ordinary Shares issuable under convertible debt | | | - | | | | - | | | | - | | | | - | | | Weighted average number of stock options | | | 177,961 | | | | 191,521 | | | | 178,977 | | | | 191,741 | | | Weighted average number of restricted stock units | | | - | | | | 78,053 | | | | - | | | | 78,681 | | | Weighted average number of warrants | | | 249,765 | | | | 608,919 | | | | 369,078 | | | | 609,380 | | | Number of shares excluded from diluted earnings (loss) per share | | | 427,726 | | | | 878,493 | | | | 548,055 | | | | 879,802 | |
|